The Effect of Novel D3 Use as a Mouthwash in COVID-19 Patients

NCT07068282 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Corona Virus Disease 19 (COVID-19)

Interventions

DRUG: Cholecalciferol (vitaminD3)

Sponsor

King Faisal Specialist Hospital & Research Center